Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle such as intake of drugs due to stress, alcohol leads to growing demand for obesity management resulting in growth of this trend.
This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Prescription Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Prescription Drugs. This report contains market size and forecasts of Anti-Obesity Prescription Drugs in global, including the following market information:
Global Anti-Obesity Prescription Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Obesity Prescription Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Obesity Prescription Drugs companies in 2022 (%)
The global Anti-Obesity Prescription Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pediatric Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Obesity Prescription Drugs include F Hoffmann La Roche Ltd, Orexigen Therapeutics, Novo Nordisk A/s, Arena Pharmaceuticals, Glaxosmithkline, Vivus, Boehringer Ingelheim and Alizyme, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Obesity Prescription Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Obesity Prescription Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Obesity Prescription Drugs Market Segment Percentages, by Type, 2022 (%)
Pediatric
Adult
Global Anti-Obesity Prescription Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Obesity Prescription Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals Pharmacies
Retail Pharmacies
E-commerce
Global Anti-Obesity Prescription Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Obesity Prescription Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Obesity Prescription Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Obesity Prescription Drugs revenues share in global market, 2022 (%)
Key companies Anti-Obesity Prescription Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Obesity Prescription Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Obesity Prescription Drugs, market overview.
Chapter 2: Global Anti-Obesity Prescription Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Obesity Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Obesity Prescription Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Obesity Prescription Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Obesity Prescription Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Obesity Prescription Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Obesity Prescription Drugs Overall Market Size
2.1 Global Anti-Obesity Prescription Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Obesity Prescription Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Obesity Prescription Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Obesity Prescription Drugs Players in Global Market
3.2 Top Global Anti-Obesity Prescription Drugs Companies Ranked by Revenue
3.3 Global Anti-Obesity Prescription Drugs Revenue by Companies
3.4 Global Anti-Obesity Prescription Drugs Sales by Companies
3.5 Global Anti-Obesity Prescription Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Obesity Prescription Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Obesity Prescription Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Obesity Prescription Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Obesity Prescription Drugs Market Size Markets, 2022 & 2029
4.1.2 Pediatric
4.1.3 Adult
4.2 By Type - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Obesity Prescription Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Obesity Prescription Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Obesity Prescription Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Obesity Prescription Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-Obesity Prescription Drugs Sales, 2024-2029
4.3.3 By Type - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Obesity Prescription Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Obesity Prescription Drugs Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.1.4 E-commerce
5.2 By Application - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Obesity Prescription Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Obesity Prescription Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Obesity Prescription Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Obesity Prescription Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-Obesity Prescription Drugs Sales, 2024-2029
5.3.3 By Application - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Obesity Prescription Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Obesity Prescription Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Obesity Prescription Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Obesity Prescription Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Obesity Prescription Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Obesity Prescription Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-Obesity Prescription Drugs Sales, 2024-2029
6.3.3 By Region - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.4.2 By Country - North America Anti-Obesity Prescription Drugs Sales, 2018-2029
6.4.3 US Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.4.4 Canada Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Obesity Prescription Drugs Sales, 2018-2029
6.5.3 Germany Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.4 France Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.6 Italy Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.7 Russia Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Obesity Prescription Drugs Sales, 2018-2029
6.6.3 China Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6.4 Japan Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6.7 India Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.7.2 By Country - South America Anti-Obesity Prescription Drugs Sales, 2018-2029
6.7.3 Brazil Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, 2018-2029
6.8.3 Turkey Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.8.4 Israel Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.8.6 UAE Anti-Obesity Prescription Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 F Hoffmann La Roche Ltd
7.1.1 F Hoffmann La Roche Ltd Company Summary
7.1.2 F Hoffmann La Roche Ltd Business Overview
7.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Major Product Offerings
7.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.1.5 F Hoffmann La Roche Ltd Key News & Latest Developments
7.2 Orexigen Therapeutics
7.2.1 Orexigen Therapeutics Company Summary
7.2.2 Orexigen Therapeutics Business Overview
7.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Major Product Offerings
7.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Orexigen Therapeutics Key News & Latest Developments
7.3 Novo Nordisk A/s
7.3.1 Novo Nordisk A/s Company Summary
7.3.2 Novo Nordisk A/s Business Overview
7.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Major Product Offerings
7.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Novo Nordisk A/s Key News & Latest Developments
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Company Summary
7.4.2 Arena Pharmaceuticals Business Overview
7.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Major Product Offerings
7.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Arena Pharmaceuticals Key News & Latest Developments
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Company Summary
7.5.2 Glaxosmithkline Business Overview
7.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Major Product Offerings
7.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Glaxosmithkline Key News & Latest Developments
7.6 Vivus
7.6.1 Vivus Company Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Anti-Obesity Prescription Drugs Major Product Offerings
7.6.4 Vivus Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Vivus Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Major Product Offerings
7.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Alizyme
7.8.1 Alizyme Company Summary
7.8.2 Alizyme Business Overview
7.8.3 Alizyme Anti-Obesity Prescription Drugs Major Product Offerings
7.8.4 Alizyme Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Alizyme Key News & Latest Developments
8 Global Anti-Obesity Prescription Drugs Production Capacity, Analysis
8.1 Global Anti-Obesity Prescription Drugs Production Capacity, 2018-2029
8.2 Anti-Obesity Prescription Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Obesity Prescription Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Obesity Prescription Drugs Supply Chain Analysis
10.1 Anti-Obesity Prescription Drugs Industry Value Chain
10.2 Anti-Obesity Prescription Drugs Upstream Market
10.3 Anti-Obesity Prescription Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Obesity Prescription Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Obesity Prescription Drugs in Global Market
Table 2. Top Anti-Obesity Prescription Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Obesity Prescription Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Obesity Prescription Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Obesity Prescription Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Obesity Prescription Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Obesity Prescription Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Anti-Obesity Prescription Drugs Product Type
Table 9. List of Global Tier 1 Anti-Obesity Prescription Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Obesity Prescription Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Obesity Prescription Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Obesity Prescription Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Obesity Prescription Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Obesity Prescription Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Obesity Prescription Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 46. F Hoffmann La Roche Ltd Company Summary
Table 47. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Offerings
Table 48. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. F Hoffmann La Roche Ltd Key News & Latest Developments
Table 50. Orexigen Therapeutics Company Summary
Table 51. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Offerings
Table 52. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Orexigen Therapeutics Key News & Latest Developments
Table 54. Novo Nordisk A/s Company Summary
Table 55. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Offerings
Table 56. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Novo Nordisk A/s Key News & Latest Developments
Table 58. Arena Pharmaceuticals Company Summary
Table 59. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Offerings
Table 60. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Arena Pharmaceuticals Key News & Latest Developments
Table 62. Glaxosmithkline Company Summary
Table 63. Glaxosmithkline Anti-Obesity Prescription Drugs Product Offerings
Table 64. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Glaxosmithkline Key News & Latest Developments
Table 66. Vivus Company Summary
Table 67. Vivus Anti-Obesity Prescription Drugs Product Offerings
Table 68. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Vivus Key News & Latest Developments
Table 70. Boehringer Ingelheim Company Summary
Table 71. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Offerings
Table 72. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Boehringer Ingelheim Key News & Latest Developments
Table 74. Alizyme Company Summary
Table 75. Alizyme Anti-Obesity Prescription Drugs Product Offerings
Table 76. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Alizyme Key News & Latest Developments
Table 78. Anti-Obesity Prescription Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Anti-Obesity Prescription Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Anti-Obesity Prescription Drugs Production by Region, 2018-2023 (K Units)
Table 81. Global Anti-Obesity Prescription Drugs Production by Region, 2024-2029 (K Units)
Table 82. Anti-Obesity Prescription Drugs Market Opportunities & Trends in Global Market
Table 83. Anti-Obesity Prescription Drugs Market Drivers in Global Market
Table 84. Anti-Obesity Prescription Drugs Market Restraints in Global Market
Table 85. Anti-Obesity Prescription Drugs Raw Materials
Table 86. Anti-Obesity Prescription Drugs Raw Materials Suppliers in Global Market
Table 87. Typical Anti-Obesity Prescription Drugs Downstream
Table 88. Anti-Obesity Prescription Drugs Downstream Clients in Global Market
Table 89. Anti-Obesity Prescription Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Obesity Prescription Drugs Segment by Type in 2022
Figure 2. Anti-Obesity Prescription Drugs Segment by Application in 2022
Figure 3. Global Anti-Obesity Prescription Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Obesity Prescription Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Obesity Prescription Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Obesity Prescription Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Obesity Prescription Drugs Revenue in 2022
Figure 9. By Type - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Obesity Prescription Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Obesity Prescription Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Obesity Prescription Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Obesity Prescription Drugs by Region, 2022 VS 2029
Figure 54. Anti-Obesity Prescription Drugs Industry Value Chain
Figure 55. Marketing Channels
